February 2022 Written by: Christian Sanfilippo, MD The Retina Partners Los Angeles, CA Lee WW, Bansal A, Sadda S, Sarraf D, Berger AR, Wong DT, Kertes PJ, Kohly RP, Hillier RJ, Muni RH. Outer Retinal Folds Following Pars Plana Vitrectomy vs Pneumatic Retinopexy for Retinal Detachment Repair: Post Hoc Analysis from PIVOT. Ophthalmol Retina. 2021 […]
February 2022 Written by: Avni P. Finn, MDAssistant ProfessorVanderbilt Eye InstituteNashville, TN Kokame GT, Yee S, Omizo JN, Villanueva L, Liu J. Laser Treatment after Minimized Eye Movement for Repair of Retinal Detachment. Ophthalmol Retina. 2021 Sep;5(9):939-941. doi: 10.1016/j.oret.2021.01.014. Epub 2021 Jan 30. PMID: 33529816. Retinal detachment repair is typically performed via three potential procedures: […]
January 2022 Written by: Rehan Hussain, MD Retina Health Institute Elgin, IL Meyer BI, Berry DE, Cribbs BE, et al. Outcomes of Infectious Endophthalmitis in Patients with Systemic Antibiotic Allergies to Penicillins, Cephalosporins, or Vancomycin. Ophthalmol Retina 2021 Sep;5(9):901-909 Infectious endophthalmitis is a rare but potentially visually devastating issue that requires prompt diagnosis […]
Written by: Jaya Badhwar Kumar, MDFlorida Retina InstituteOrlando, FL January 2022 Newman-Casey, Paula Anne et al. Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience. Am J Ophthal, 2021. 230: 234 –242. In the era of a global pandemic, the demand for telehealth services has expanded across all fields of medicine […]
Written by: Priya Sharma Vakharia, MDRetina Vitreous Associates of FloridaPalm Harbor & St. Petersburg, FL January 2022 Ung C, Yonekawa Y, Waljee J, et al. Persistent opioid use after ophthalmic surgery in opioid-naïve patients and associated factors. Ophthalmology 2021; 128(9): 1266-1273. This is a retrospective claims-based cohort analysis, using a database (Optum ClinformaticsÒ DataMart Database) […]
Written by: Wenlan (Wendy) Zhang, MD October 2021 Lauermann P, Klingelhöfer A, Mielke D, van Oterendorp C, Hoerauf H, Striebe NA, Storch MW, Pfeiffer S, Koscielny J, Sucker C, Bemme S, Feltgen N. Risk Factors for Severe Bleeding Complications in Vitreoretinal Surgery and the Role of Antiplatelet or Anticoagulant Agents. Ophthalmol Retina. 2021 Aug;5(8):e23-e29. Many […]
Written by: Musa Abdelaziz, MD October 2021 Fang, Y et al. “Development of macular atrophy after pars plana vitrectomy for myopic traction maculopathy and macular hole retinal detachment in pathologic myopia.” Retina. 2020 Oct;40(10):1881-1893. DOI: 10.1097/IAE.0000000000002709. Pathologic myopia (PM) is a major cause of legal blindness worldwide. The most serious lesion associated with severe vision […]
Written by: Philip P. Storey, MD October 2021 Khanani A, Callanan D, Dreyer R, Chen S, Howard J, Hopkins J, Lin C, Lorenz-Candlin M, Makadia S, Patel S, Tam T, Gune S. End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina 2021;5:775-787. […]
